|
Sign In to gain access to subscriptions and/or personal tools.
|
Biomaterials & Bioengineering |
Platelet-rich Plasmas: Growth Factor Content and Roles in Wound Healing
J.-P. Fréchette,
I. Martineau and
G. Gagnon*
Faculté de médecine dentaire, Université Laval, Québec, Province Québec, Canada G1K 7P4;
Correspondence: * corresponding author, guy.gagnon{at}fmd.ulaval
Platelet-rich plasmas (PRPs) are used in a variety of clinical applications, based on the premise that higher growth factor content should promote better healing. In this study, we have determined the effects of calcium and thrombin on the release of EGF, TGF- , IGF-1, Ang-2 and IL-1β from PRPs, and assessed the mitogenic potential of PRP supernatants on osteoblast and endothelial cell division. ELISA assays indicate that (i) mean growth factor concentrations vary from traces (TGF- ) to 5.5 ng/mL (IGF-1), (ii) there are significant variations in growth factor concentrations between individuals, and (iii) calcium and thrombin regulate growth factor release, synthesis, and/or degradation in stereotyped patterns that are specific to each growth factor. PRP supernatants promote strong osteoblast and endothelial cell divisions, supporting the concept that PRPs may be beneficial in wound healing. Abbreviations: PRPs, platelet-rich plasmas; GFs, growth factors; EGF, epidermal growth factor; TGF- , transforming growth factor-alpha; IGF-1, insulin-like growth factor-1; Ang-2, angiopoietin-2; IL-1β, interleukin-1 beta; HUVECs, human umbilical vein endothelial cells; hFOB 1.19, human fetal osteoblasts; and FBS, fetal bovine serum.
Key Words: platelet-rich plasma growth factors endothelial cells osteoblasts wound healing
Journal of Dental Research, Vol. 84, No. 5,
434-439 (2005)
DOI: 10.1177/154405910508400507

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
G. Pietramaggiori, S. S. Scherer, D. Cervi, G. Klement, and D. P. Orgill
Tumors Stimulate Platelet Delivery of Angiogenic Factors in Vivo: An Unexpected Benefit
Am. J. Pathol.,
December 1, 2008;
173(6):
1609 - 1616.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L Creaney and B Hamilton
Growth factor delivery methods in the management of sports injuries: the state of play
Br. J. Sports Med.,
May 1, 2008;
42(5):
314 - 320.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. S. Agren and M. Werthen
The Extracellular Matrix in Wound Healing: A Closer Look at Therapeutics for Chronic Wounds
International Journal of Lower Extremity Wounds,
June 1, 2007;
6(2):
82 - 97.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
T. M. Bielecki, T. S. Gazdzik, J. Arendt, T. Szczepanski, W. Krol, and T. Wielkoszynski
Antibacterial effect of autologous platelet gel enriched with growth factors and other active substances: AN IN VITRO STUDY
J Bone Joint Surg Br,
March 1, 2007;
89-B(3):
417 - 420.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Ranly, C. H. Lohmann, D. Andreacchio, B. D. Boyan, and Z. Schwartz
Platelet-Rich Plasma Inhibits Demineralized Bone Matrix-Induced Bone Formation in Nude Mice
J. Bone Joint Surg. Am.,
January 1, 2007;
89(1):
139 - 147.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Li, R. E. Rumbaut, A. R. Burns, and C. W. Smith
Platelet Response to Corneal Abrasion Is Necessary for Acute Inflammation and Efficient Re-epithelialization
Invest. Ophthalmol. Vis. Sci.,
November 1, 2006;
47(11):
4794 - 4802.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|